These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16126317)

  • 1. Signs of cyclosarin-induced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators.
    Krejcova-Kunesova G; Bartosova L; Kuca K
    Toxicology; 2005 Dec; 216(1):32-40. PubMed ID: 16126317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of neuroprotective efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
    Kassa J; Karasova J; Vasina L
    J Appl Toxicol; 2007; 27(6):621-30. PubMed ID: 17685413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Karasova J
    Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
    Kassa J; Karasova JZ; Bajgar J; Tesarova S; Kuca K; Musilek K
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):228-35. PubMed ID: 19143747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidotal treatment of GF-agent intoxication in mice with bispyridinium oximes.
    Sevelová L; Kuca K; Krejcová-Kunesová G
    Toxicology; 2005 Feb; 207(1):1-6. PubMed ID: 15590116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefit of combination of oximes for the neuroprotective efficacy of antidotal treatment of sarin-poisoned rats.
    Kassa J; Kunesova G
    Toxicol Mech Methods; 2012 May; 22(4):260-7. PubMed ID: 22149934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Kunesova G
    J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the ability of newly-developed bispyridinium oxime K203 and currently available oximes (trimedoxime, obidoxime, HI-6) to counteract the acute neurotoxicity of soman in rats.
    Kassa J; Karasova JZ; Tesarova S; Kuca K; Musilek K
    Toxicol Mech Methods; 2010 Oct; 20(8):445-51. PubMed ID: 20738156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
    Bartosova L; Kuca K; Jun D; Kunesova G
    Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
    Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
    Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo reactivation by oximes of inhibited blood, brain and peripheral tissue cholinesterase activity following exposure to nerve agents in guinea pigs.
    Shih TM; Skovira JW; O'Donnell JC; McDonough JH
    Chem Biol Interact; 2010 Sep; 187(1-3):207-14. PubMed ID: 20223229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the neuroprotective efficacy of newly developed oximes (K156, K203) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
    Kassa J; Karasová JZ; Tesarová S; Kuca K; Musílek K
    Acta Medica (Hradec Kralove); 2008; 51(4):215-21. PubMed ID: 19453087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of the neuroprotective effects of bispyridinium oximes in tabun-poisoned rats.
    Kassa J; Karasova J
    J Toxicol Environ Health A; 2007 Sep; 70(18):1556-67. PubMed ID: 17710615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats.
    Kassa J; Jun D; Kuca K; Bajgar J
    Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):328-32. PubMed ID: 17910616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
    Kassa J; Misik J; Karasova JZ
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):333-8. PubMed ID: 22536919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of currently used antidotes in tabun-poisoned rats.
    Kassa J; Krejèová G
    Pharmacol Toxicol; 2003 Jun; 92(6):258-64. PubMed ID: 12787257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
    Shih TM; Skovira JW; O'Donnell JC; McDonough JH
    Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.